LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2
Authors
Keywords
Leucine-rich repeats and immunoglobulin-like domains 1(LRIG1), Multidrug resistance (MDR), Epidermal growth factor receptor (EGFR), ATP-binding cassette, Sub-family B member 1(ABCB1), ATP-binding cassette, Sub-family G (WHITE), Member 2 (ABCG2)
Journal
BRAIN RESEARCH
Volume 1611, Issue -, Pages 93-100
Publisher
Elsevier BV
Online
2015-04-09
DOI
10.1016/j.brainres.2015.03.023

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.